Paolo Cavazza
Keine laufenden Positionen mehr
Vermögen: 11 Mio $ am 30.04.2024
Profil
Paolo Cavazza worked as a Principal at SciClone Pharmaceuticals LLC.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2023 | 76 580 898 ( 13,01% ) | 11 Mio $ | 30.04.2024 |
Ehemalige bekannte Positionen von Paolo Cavazza
| Unternehmen | Position | Ende |
|---|---|---|
| SCICLONE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
